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ABSTRACT 
Background 
Loneliness, or the perceived discrepancy between the quantity and quality of ones’ actual 
social relationships and desired level of connectedness, is a potentially important psychosocial 
factor in lung cancer patients. The purpose of the current study was to investigate the relationship 
of loneliness to depressive symptoms, quality of life, and social-cognitive variables and to 
explore the role of loneliness in mediating relationships between social-cognitive variables and 
depressive symptoms and quality of life. Finally, the study examined whether loneliness 
predicted change over time in depressive symptoms and quality of life. 
Methods 
Lung cancer patients were recruited from the Moffitt Cancer Center Thoracic Oncology 
Clinic to complete two study questionnaires via hard copy or online. Participants completed 
measures of loneliness (UCLA V3), depressive symptoms, (CES-D) and quality of life (FACT-
L) at baseline and 30 days later. Participants also completed measures of demographic 
characteristics and social-cognitive variables, including cancer-related stigma (CLCSS), cancer-
related negative social expectations (CNSES), social constraint (SCS), avoidant coping (CRI – 
avoidant coping), and beliefs about one’s ability to cope with cancer (CBI-B) at baseline. 
Clinical characteristics were assessed via medical record review. 
Results 
Participants (n = 109) reported a low to moderate level of loneliness (M = 33.8), and 38% 
reported clinically significant (CES-D > 16) depressive symptoms. Quality of life in the current
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study (M = 98.1) was consistent with normative FACT-L data collected from a sample of lung 
cancer patients. Loneliness was positively correlated with depressive symptoms (r = .44) and 
negatively correlated with quality of life (r = -.59). In addition, loneliness was positively 
correlated with social-cognitive variables in the expected directions and social-cognitive 
variables were related to depressive symptoms and quality of life in the expected directions (p’s 
< .001). Mediation analyses yielded evidence for partial mediation, with loneliness mediating the 
relationships of social-cognitive variables with depressive symptoms and quality of life for nine 
of the ten models tested. The exception was findings showing that loneliness did not mediate the 
relationship between beliefs about one’s ability to cope with cancer and depressive symptoms. 
Loneliness at Time 1 predicted additional variance in depressive symptoms at Time 2 (Β = .38, 
Adj R2 = .31) after accounting for depressive symptoms at Time 1, but loneliness at Time 1 did 
not account for additional variance in quality of life at Time 2 after accounting for quality of life 
at Time 1. 
Conclusions 
Results suggest that consideration of loneliness is important in order to understand 
differences in depressive symptoms and quality of life in lung cancer patients. Beyond its direct 
impact on clinically relevant outcomes, the experience of loneliness may be the mechanism by 
which social-cognitive factors influence depressive symptoms and quality of life. Investigation 
of the relationship between stigma and loneliness in the context of lung cancer is particularly 
novel and warrants further exploration. 
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INTRODUCTION 
Lung cancer is a significant public health problem in the United States, with an estimated 
234,000 new cases to be diagnosed in 2018 (American Cancer Society, 2018). Lung cancer is the 
second most frequently diagnosed cancer in both men and women and is responsible for the most 
cancer deaths annually, with a projected 154,000 people dying of the disease this year (American 
Cancer Society, 2018). Unfortunately, the prognosis for lung cancer is poor, with a 5-year 
survival rate of 56% when diagnosed at a localized stage and 18% overall (American Cancer 
Society, 2018). Treatment regimens for lung cancer are intensive, often consisting of surgery, 
systemic therapy, and/or radiotherapy. Symptom burden is high, with primary complaints of 
fatigue, dyspnea, pain, insomnia, and appetite loss (Braun, Gupta, & Staren, 2011; Buzaglo et al., 
2014; Chen, Yu, &Yang, 2008; Cooley, 2000; Tishelman, Lövgren, Broberger, Hamberg, & 
Sprangers, 2010).  
In light of the significant symptom burden, lung cancer patients often suffer from disease- 
and treatment-related psychosocial morbidity (Graves et al., 2007; Steinberg et al., 2009; Zabora, 
BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001). It is well documented that lung cancer 
patients report elevated rates of depressive symptoms (Chambers et al., 2015; Gonzalez & 
Jacobsen, 2012; Hopwood & Stephens, 2000; Linden, Vodermaier, Mackenzie, & Greig, 2012a; 
Muzzatti et al., 2016; Sarna et al., 2005) and diminished overall quality of life (Hulbert-
Williams, Neal, Morrison, Hood, & Wilkinson, 2012; Poghosyan, Sheldon, Leveille, & Cooley, 
2013; Polanski, Jankowska-Polanska, Rosinczuk, Chabowski, & Szymanska-Chabowska, 2016; 
Schag, Ganz, Wing, Sim, & Lee, 1994). Beyond symptom burden, there is a limited 
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understanding of factors associated with depressive symptoms and quality of life in lung cancer 
patients. Loneliness, or the subjective negative experience of deficits in social relationships, is 
one such factor that may be associated with these outcomes (De Jong-Gierveld, 2006; Peplau & 
Perlman, 1979, 1982). The purpose of the current study was to investigate the relationship of 
loneliness to depressive symptoms and quality of life in a sample of lung cancer patients. The 
study also sought to identify social-cognitive variables associated with loneliness and to explore 
the role of loneliness in mediating relationships between these variables and depressive 
symptoms and quality of life. Finally, the study examined whether loneliness predicted change 
over time in depressive symptoms and quality of life. 
A significant body of research to date has focused on demographic and clinical correlates 
of depressive symptoms and quality of life outcomes in cancer patients. Lung cancer patients are 
at increased risk for depressive symptoms, with rates of clinically significant depressive 
symptoms ranging from 11-50% (Gonzalez & Jacobsen, 2012; Graves et al., 2007; Hopwood & 
Stephens, 2000; Massie, 2004). Female gender, a diagnosis of small cell (versus non-small cell) 
lung cancer, and more advanced disease are risk factors for depressive symptoms in lung cancer 
(Carlsen, Jensen, Jacobsen, Krasnik, & Johansen, 2005; Hopwood & Stephens, 2000; 
Vodermaier, Linden, MacKenzie, Greig, & Marshall, 2011). Worse overall quality of life has 
been associated with demographic factors, such as age (worse in younger patients and those > 65 
years old) (Möller & Sartipy, 2012; Sarna et al., 2005) and lower socioeconomic status 
(Montazeri, Hole, Milroy, McEwen, & Gillis, 2003), and clinical correlates, such as more 
advanced disease, disease progression, and treatment intensity (Bernhard et al., 1996; Möller & 
Sartipy, 2012; Polanski et al., 2016). While informative in determining risk profiles, these factors 
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are not generally amenable to intervention. To date, there is limited understanding of modifiable 
psychosocial factors that impact depressive symptoms and quality of life related to lung cancer.  
Loneliness is a potentially important psychosocial factor in general and in cancer 
populations. Loneliness is not simply being alone, but rather a perceived discrepancy between 
the quantity and quality of ones’ actual social relationships and desired level of connectedness 
(Peplau & Perlman, 1979; 1982; Perlman & Peplau, 1981, 1998). Theories of social and 
evolutionary psychology posit that humans are social creatures who require interaction to 
survive, and so a perceived deficit in relationships is both negative and distressing (Cacioppo et 
al., 2006a; Hawkley & Cacioppo, 2010; Perlman & Peplau, 1998). The social-cognitive 
conceptualization of loneliness states that cognitive, behavioral, and environmental factors 
(specifically the social environment) influence one another to shape how an individual perceives, 
experiences, and evaluates their social relationships (Bandura, 1986; De Jong-Gierveld, 1987, 
1998; Hawkley & Cacioppo, 2010) As the social-cognitive model suggests, a combination of 
dispositional and situational factors may precipitate and sustain loneliness (De Jong-Gierveld, 
1998; Peplau & Perlman, 1979). Objective characteristics of the social network (e.g., number of 
friends) poorly predict loneliness, supporting its conceptualization as a subjective experience 
(Cutrona, 1986). Loneliness in the general population has been associated with female gender, 
being unpartnered, lesser educational attainment, and lower socioeconomic status (Peplau & 
Perlman, 1979). Loneliness demonstrates a U-shaped relationship with age, with greater 
prevalence in young adults (Rokach, 2000b) and older adults (Cacioppo, Hughes, Waite, 
Hawkley, & Thisted, 2006b; Cacioppo, Hawkley, & Thisted, 2010; Cohen-Mansfield, Hazan, 
Lerman, & Shalom, 2016; Hawkley & Cacioppo, 2007; Pinquart & Sorensen, 2001; Steptoe, 
Shankar, Demakakos, & Wardle, 2013). Persistent loneliness is estimated to be present in 15-
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30% of the general population and can have detrimental consequences for physical, mental, and 
emotional health (Hawkley & Cacioppo, 2010; Heinrich & Gullone, 2006; Peplau & Perlman, 
1982). Loneliness has been shown to predict increased morbidity and mortality through a variety 
of pathways, including diminished engagement in protective health behaviors, poor sleep quality, 
and physiological, genetic, immunoregulatory, and neuroendocrine processes (Cacioppo, 2002; 
Cacioppo & Hawkley, 2009; Hawley & Cacioppo, 2003, 2010; Jaremka et al., 2013b; You, Yeh, 
& Su, 2014).  
Loneliness may be precipitated by situational happenings, such as a major life event or 
stressor. A cancer diagnosis is one such stressor, impacting nearly every aspect of an individuals’ 
life including social relationships (Adams et al, 2016a; Friedman, Florian, & Zernitsky-Shurka, 
1989; Jefferies & Clifford, 2011; Karhe & Kaunonen, 2015; Linden &Vodermaier, 2012b; 
Rokach, 2000a; Rosedale, 2009). A recent meta-analysis of 15 studies of loneliness in cancer 
patients found a weighted mean loneliness score on the UCLA Loneliness Scale of 38.26 (Range 
= 20-80, higher = more lonely), which corresponds with a moderate level of loneliness (Deckx, 
van den Akker, & Buntinx, 2014). It should be noted that none of these studies focused 
specifically on lung cancer patients and evidence suggests that lung cancer patients may be 
particularly vulnerable to loneliness. Qualitative explorations consistently show that lung cancer 
patients identify loneliness as a factor impacting their lives (Buzaglo et al., 2014; Ekfors & 
Petersson, 2004; Refsgaard, 2013). In a quantitative exploration of social isolation in lung cancer 
patients, 50% of patients endorsed high levels of social isolation (McGeough, Edwards, 
Chamberlain, & Nogeire, 1980). 
Loneliness and depression are related constructs, and widely used measures of both 
suggest they are moderately correlated (r = .42 - .68) (Cacioppo et al., 2010; Russell, Cutrona, 
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Rose, & Yurko, 1984; Russell, 1996). However, multiple studies have established that, while 
related, loneliness and depression are unique constructs worthy of independent study (Cacioppo 
et al., 2006b; Russell, 1996; Weeks, Michela, Peplau, & Bragg, 1980). Cacioppo and colleagues 
have conducted several longitudinal studies in population-based samples of middle-aged and 
older adults to elucidate the relationship between these two variables. Results suggest that 
loneliness predicts change in depressive symptoms over time, but depressive symptoms do not 
predict changes in loneliness (Cacioppo et al., 2006b, 2010).  
Quality of life is a multidimensional concept that encompasses functional, emotional, 
physical, and social well-being. Patient-reported quality of life is frequently used as an outcome 
measure in lung cancer research in order to document the impact of the disease and its treatment 
from the patient perspective. Loneliness has been shown to predict worse quality of life, 
particularly in older adults (Brown, Thompson, Zack, Arnold, & Barile, 2015; Ekwall, Sivberg, 
& Hallberg, 2004; Musich, Wang, Hawkins, & Yeh, 2015; Steptoe et al., 2013; Theeke, Goins, 
Moore, & Campbell, 2012). This has importance given that adults over 65 account for 60% of 
new cancer diagnoses annually (Berger et al., 2006).  
Several studies to date have examined the relationship of loneliness to depression and 
quality of life in cancer patients. Loneliness has been shown to be a risk factor for current and 
future depressive symptomology in samples of cancer survivors (Jaremka et al., 2013a, 2014). 
Loneliness has also been associated with worse overall quality of life in cancer patients (Boer, 
Elving, & Seydel, 1998; Deckx et al., 2013). While relationships of loneliness with depression 
and quality of life have been described in cancer patients, this has not been fully explored in lung 
cancer patients. 
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A number of studies have examined the demographic and clinical correlates of loneliness 
in people with cancer. A recent systematic review examining risk factors for loneliness in cancer 
patients identified 15 quantitative studies that used a validated measure of general loneliness.  
Being unmarried was found to be associated with greater levels of loneliness in patients with 
cancer (Deckx et al., 2015; Friedman et al., 1989; Perry, 1990; Yildirim & Kocabiyik, 2010), 
while other demographic factors including age, gender, education, income, and employment 
status have demonstrated mixed results (Avci & Kumcagiz, 2011; Deckx et al., 2013, 2015; 
Pehlivan, Ovayolu, Ovayolu, Sevinc, & Camci, 2011; Perry, 1990; Sevil, Ertem, Kavlak, & 
Coban, 2006; Yildirim & Kocabiyik, 2010). Clinical variables including cancer type, disease 
stage, and type of treatment were not associated with level of loneliness (Pehlivan et al., 1990; 
Sevil et al., 2006; Yildirim & Kocabiyik, 2010), but time since diagnosis was positively 
associated with loneliness, such that individuals more than one year from diagnosis were lonelier 
than those who were within a year since diagnosis (Deckx et al., 2014).  
While there is limited evidence that demographic and clinical variables are related to 
loneliness, social-cognitive theory and previous research can be used to identify a number of 
social-cognitive variables that may contribute to loneliness in cancer patients, as well as greater 
depressive symptomatology and worse quality of life. Moreover, it can be theorized that the 
relationship of these variables to depression and quality of life is mediated by loneliness (Figure 
1).  
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Among cancers, health-related stigma is relatively unique to lung cancer in that there is an 
established causal relationship between cigarette smoking and lung cancer (Chapple, Ziebland, & 
McPherson, 2004; LoConte, Else-Quest, Eickhoff, Hyde, & Schiller, 2008; National Center for 
Chronic Disease Prevention and Health Promotion, 2014). Stigmatization occurs when an 
individual is considered to be part of a marginalized group due to a personal characteristic 
(Goffman, 1963). Lung cancer stigma has been conceptualized as the product of several factors 
occurring in tandem, including societal awareness of the connection between lung cancer and 
cigarette smoking, the resultant experience of discrimination and isolation that often 
accompanies a lung cancer diagnosis, and an individuals’ response to these factors (Brown 
Johnson, Brodsky, & Cataldo, 2014). Because lung cancer is perceived by many as being self-
inflicted, patients with this disease may experience greater levels of perceived and internalized 
stigma (Hamann et al., 2014; Stuber, Galea, & Link, 2008). Perceived stigma causes fear of 
rejection and is associated with limited use of social support, which may result in greater feelings 
of loneliness (Cataldo, Slaughter, Jahan, Pongquan, & Hwang, 2011). Greater perceived stigma 
  
  
• Perceived Stigma	
• Social Constraint	
• Cancer-Related Negative 
Social Expectations	
• Cancer Self-Efficacy	
• Avoidant Coping	
Loneliness 
  
Depression 
Quality of Life 
Figure 1. Model of Loneliness Mediating the Relationship Between 
Psychosocial Factors with Depression and Quality of Life 
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has been associated with greater depressive symptomology (Brown Johnson et al., 2014; Cataldo 
et al., 2011, Cataldo, Jahan, & Pongquan, 2012; Else-Quest, LoConte, Schiller, & Hyde, 2009; 
Gonzalez & Jacobsen, 2012), and worse quality of life in lung cancer patients (Brown Johnson et 
al., 2014; Cataldo et al., 2011, 2012; Chambers et al., 2012, 2015). Interestingly, lung cancer 
patients may experience perceived stigma related to their diagnosis regardless of personal 
smoking history (Brown Johnson et al., 2014; Carter-Harris, 2015; Cataldo et al., 2012; Criswell, 
Owen, Thornton, & Stanton, 2016). 
Social constraint occurs when an individual feels unable to discuss the thoughts and 
feelings associated with a trauma, such as cancer diagnosis and treatment, with people around 
them (Lepore & Revenson, 2007). Lung cancer patients may feel socially constrained in 
discussing their cancer due to personal fears of rejection or feelings of disease-related shame and 
guilt, or secondary to responses from others in previous attempts at these discussions, including 
avoidance, criticism, and conflict, discouraging future attempts at discussion (Badr & Taylor, 
2006; Dirkse et al., 2014). According to social-cognitive processing theory, this constraint on 
discussion about the stressor impedes cognitive processing and adjustment, potentially increasing 
loneliness (Lepore, 2001); indeed, social constraint has been correlated with loneliness in cancer 
survivors (Mosher et al., 2012). Lung cancer patients may be particularly vulnerable to social 
constraint due to sensitive issues common to these patients (Badr & Taylor, 2006; Dirkse et al., 
2014; Herzer, Zakowski, Flanigan, & Johnson, 2006), including continued tobacco use and poor 
disease prognosis. In addition, lung cancer patients report more difficulties communicating with 
their partners as compared to patients with other cancer diagnoses (Schag et al., 1994). Social 
constraint has been associated with worse mental and physical health outcomes in cancer patients 
and survivors, including greater symptom burden, cancer-specific distress, more depressive 
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symptoms, and worse quality of life (Adams et al., 2015, 2016b; Cordova, Cunningham, Carlson, 
& Andrykowski, 2001; Lepore & Revenson, 2007). While a large body of literature has 
emphasized the importance of social support in promoting positive psychosocial outcomes, fewer 
studies have examined the influence of social constraint, despite evidence that negative 
interactions may have a greater impact on health outcomes (Lepore & Ituarte, 1999; Lepore & 
Revenson, 2007; Manne, Taylor, Dougherty, & Kemeny, 1997; Manne & Glassman, 2000; 
Manne, Ostroff, Winkel, Grana, & Fox, 2005).  
Cancer-related negative social expectations may precipitate and sustain loneliness 
(Adams et al., 2017a; Cacioppo & Hawkley, 2009). Cacioppo & Hawkley suggest that loneliness 
functions as a negative feedback loop whereby lonelier individuals expect more negative social 
interactions and therefore experience them as such (Cacioppo et al., 2006b; Hawkley & 
Cacioppo, 2010). Lonely lung cancer patients may experience greater perceived stigma and feel 
socially constrained in discussing their cancer-related thoughts and emotions, leading these 
patients to approach future social situations with negative expectations and creating a further 
divide between the patient and those around them, resulting in greater depressive symptomology 
(Cacioppo & Hawkley, 2009). Cancer-related negative social expectations have been positively 
correlated with loneliness and depressive symptoms, and negatively correlated with quality of 
life (Adams et al., 2017a). 
In contrast, greater cancer self-efficacy, or ones belief in their ability to engage in 
behaviors to manage their cancer diagnosis and treatment, is associated with better physical 
(lesser symptom burden) and psychosocial (lesser depressive symptoms, better quality of life) 
health outcomes in mixed cancer samples (Boer et al., 1998; Cleary & Stanton, 2015; 
Cunningham, Lockwood, & Cunningham, 1991; Heitzmann et al., 2011; Hoffmann, Lent, & 
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Raque-Bogdan, 2012; Liao et al., 2014; Manne & Glassman, 2000; Merluzzi, Nairn, Hegde, 
Martinez Sanchez, & Dunn, 2001; Philip, Merluzzi, Zhang, & Heitzmann, 2013). Patients with 
low cancer self-efficacy may perceive themselves as lacking the capability, support, and 
resources to navigate their cancer, leading these patients to feel lonelier in their cancer 
experience (Cleary & Stanton, 2015; Peplau & Perlman, 1982). Low self-efficacy has been 
associated with loneliness in older adults in the general population (Fry & Debats, 2002; Cohen-
Mansfield et al., 2016) and in a sample of breast cancer patients (Cleary & Stanton, 2015).  
Coping responses, or the techniques one employs to cope with the cancer experience, can 
also impact disease processing, adjustment, and outcomes. Lung cancer patients who employ 
more avoidant coping responses, such as cognitive avoidance and denial, experience worse 
quality of life and health outcomes and greater depressive symptomology (Gonzalez & Jacobsen, 
2012; Nipp et al., 2016). Research also suggests that patients who use avoidant coping strategies 
when dealing with cancer are lonelier (Cacioppo et al., 2000; Perry, 1990; Rokach, 2000a). 
Cancer patients, particularly those diagnosed with lung cancer, may experience loneliness 
invoked by each of these social-cognitive factors, and there is evidence that each of these factors 
is associated with depressive symptomology and worse quality of life, suggesting that loneliness 
may act as a mediator. Loneliness has been identified as an understudied mediator variable in the 
cancer literature (Cleary & Stanton, 2015; Lepore & Revenson, 2007; Mosher et al., 2012). 
Studies that have utilized loneliness as a mediator support its inclusion in psychosocial models. 
For example, loneliness has been shown to mediate the relationship between social constraint 
and distress in patients who have undergone hematopoietic stem cell transplantation (Mosher et 
al., 2012). Cancer-related loneliness has also been shown to mediate the relationship between 
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social constraint and symptoms such as pain, fatigue, sleep disturbance, and cognitive 
impairment in a mixed cancer sample (Adams, Mosher, Winger, Abonour & Kroenke, 2017b). 
Loneliness is a clinically relevant variable and a potential intervention target. As noted 
above, loneliness is associated with greater depressive symptomology and worse overall quality 
of life in cancer patients (Boer et al., 1989; Deckx et al., 2014; Jaremka et al., 2013a, 2014). 
Loneliness has also been identified as a risk factor for decreased survival time and overall 
mortality in general and cancer samples (Drageset, Eide, Kirkevold, & Ranhoff, 2013; Fox, 
Harper, Hyner, & Lyle, 1994; Holt-Lunstad, Smith, Baker, Harris, & Stephenson, 2015). A 
recent meta-analysis of interventions to reduce loneliness identified improving and enhancing 
social support, increasing opportunities for social contact, and addressing maladaptive social 
cognitions as primary intervention strategies (Masi, Chen, Hawkley, & Cacioppo, 2011). Masi 
and colleagues (2011) found that social-cognitive interventions, specifically the provision of 
cognitive behavioral therapy to change maladaptive social cognitions, were significantly more 
effective at reducing loneliness than those aimed at bolstering social support, skills, or access. 
However, there have been no intervention trials to date targeting loneliness in cancer patients and 
studies that have used social support-based interventions have been unsuccessful (Coleman et al., 
2005), unless combined with additional psychosocial and educational components (Fukui, Koike, 
Ooba, & Uchitomi, 2003; Samarel, Tulman, & Fawcett, 2002). Thus, the current study can help 
to inform the development of future social-cognitive interventions for loneliness in cancer 
patients by evaluating novel social-cognitive intervention targets as they relate to loneliness as 
well as depression and quality of life. 
The dynamic nature of the cancer experience justifies the measurement of depressive 
symptoms and quality of life over time. Depressive symptoms and quality of life may change 
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frequently in the context of clinical features, such as increased symptom burden and disease 
progression (Pearman, 2007). Both depressive symptoms (Pinquart & Sorensen, 2010; Satin, 
2009) and worse quality of life (Eton et al., 2003; Montazeri, 2009; Sloan et al., 2012) have been 
associated with worse treatment response and increased risk of mortality in cancer patients. 
Therefore, it is important to identify whether psychosocial factors like loneliness can predict 
changes in depressive symptomology and quality of life over time. Accordingly, the present 
study examined whether loneliness predicted changes in depressive symptomology and quality 
of life over a 30-day follow-up period.  
 
 
Aims of the Current Study 
 
With this literature as background and these considerations in mind, the aims of the 
present study are presented below. Aims 1-4 utilized cross-sectional data collected at the initial 
assessment point (Time 1), while Aim 5 utilized longitudinal data collected at Time 1 and 30 
days later (Time 2).  
Aim 1. To examine the relationship of loneliness with depressive symptoms and quality of 
life in lung cancer patients.  
Hypothesis 1: Lonelier lung cancer patients will report more depressive symptoms and worse 
quality of life. 
Aim 2. To investigate the relationship of perceived stigma, social constraint, cancer-related 
negative social expectations, cancer self-efficacy, and avoidant coping with depressive 
symptoms and quality of life in lung cancer patients.  
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Hypothesis 2a: Lung cancer patients who endorse greater perceived stigma will report more 
depressive symptoms and worse quality of life. 
Hypothesis 2b: Lung cancer patients who are more socially constrained will report more 
depressive symptoms and worse quality of life. 
Hypothesis 2c: Lung cancer patients who endorse more negative social expectations will report 
more depressive symptoms and worse quality of life. 
Hypothesis 2d: Lung cancer patients with less confidence in their ability to engage in positive 
cancer management behaviors (cancer self-efficacy) will report more depressive symptoms and 
worse quality of life. 
Hypothesis 2e: Lung cancer patients who engage in more avoidant coping strategies will report 
more depressive symptoms and worse quality of life. 
Aim 3. To investigate the relationship of perceived stigma, social constraint, cancer-related 
negative social expectations, cancer self-efficacy, and avoidant coping with loneliness in 
lung cancer patients.  
Hypothesis 3a: Lung cancer patients who endorse greater perceived stigma will be lonelier. 
Hypothesis 3b: Lung cancer patients who are more socially constrained will be lonelier. 
Hypothesis 3c: Lung cancer patients who endorse more negative social expectations will be 
lonelier. 
Hypothesis 3d: Lung cancer patients with less confidence in their ability to engage in positive 
cancer management behaviors (cancer self-efficacy) will be lonelier. 
Hypothesis 3e: Lung cancer patients who engage in more avoidant coping strategies will be 
lonelier. 
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Aim 4. To explore whether loneliness mediates the relationship of perceived stigma, social 
constraint, cancer-related negative social expectations, cancer self-efficacy, and avoidant 
coping with depressive symptoms and quality of life in lung cancer patients. 
Aim 5. To explore whether loneliness at Time 1 predicts changes in depressive symptoms 
and quality of life between Time 1 and Time 2.
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METHODS 
 
Participants 
Participants were patients who met the following eligibility criteria: 1) diagnosed with 
lung cancer, 2) within three months of beginning systemic therapy or radiotherapy for lung 
cancer, 3) had not received treatment for cancer other than lung or non-melanoma skin cancer 
within the past five years, 4) able to read and speak English, 5) 18 years of age or older, 6) able 
to provide informed consent, and 7) receiving treatment at Moffitt Cancer Center.  
Procedure  
This study was approved the University of South Florida Institutional Review Board (IRB). 
Study eligibility was determined by medical record review and consultation with Moffitt Cancer 
Center Thoracic Oncology 
Program team members. 
Potentially eligible patients were 
approached by trained research 
staff during a scheduled 
appointment at the Moffitt Cancer 
Center. The study protocol was 
explained by research staff. 
Eligible patients interested in participation provided written informed consent. Participants were 
then given the option to complete the Time 1 study questionnaire in a hard copy form, either in
Table 1. Measures Collected 
Variables  T1 (Initial)  T2 (Day 30) 
Sociodemographics X  
Clinical Characteristics X  
Loneliness  X X 
Depression  X X 
Quality of Life  X X 
Perceived Stigma  X  
Social Constraint  X  
Cancer-related Negative 
Social Expectations  
X  
Cancer Self-Efficacy  X  
Avoidant Coping  X  
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 clinic or at home, or to complete measures online via a unique secure web-based survey link. 
Patients who opted to complete the hard copy version at home were provided with a postage-paid 
self-addressed envelope for return mailing. Participants who chose to complete the web-based 
version were asked for their preferred email address, and provided with instructions for accessing 
the secure web-based questionnaire. The Time 1 questionnaire took approximately 30 minutes to 
complete. Thirty days after completion of the Time 1 questionnaire, participants were sent the 
Time 2 questionnaire in their preferred method of transmission. The hard copy version was sent 
to participants via FedEx with a postage-paid self-addressed envelope for return mailing, while 
the online version was sent via secure email link to the participants’ preferred email address. The 
Time 2 questionnaire took approximately 15 minutes to complete. Participants were not 
compensated for their participation in the study. 
 
Measures 
Sociodemographic Characteristics – Participants completed a standardized self-report 
form to collect relevant demographic information, including age, sex, marital status, race, 
ethnicity, education, employment status, and performance status. The abbreviated Lubben Social 
Network Scale (LSNS-6) assessed size, closeness, and frequency of contact with ones’ social 
network (Gray, Kim, Ciesla, & Yao, 2016; Lubben et al., 2006; Novotny et al., 2010). 
Additionally, two items from the Social Network Index (SNI) assessed religious affiliation and, 
if present, frequency of contact with members of the religious network (Cohen, Doyle, Skoner, 
Rabin, & Gwaltney, 1997). 
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Clinical Characteristics – Relevant clinical information was collected via medical record 
review, including date of cancer diagnosis, cancer type, disease stage, date(s) of treatment and 
type(s) of treatment. 
Loneliness – Participants completed the 20-item UCLA Loneliness Scale - Version 3 
(Russell, 1996) to measure subjective feelings of loneliness. Participants were asked to rate how 
often each statement is descriptive of them on a four-point Likert scale ranging from 1 (never) to 
4 (often). Items were summed to create a total score ranging from 20 to 80, with higher scores 
indicating greater loneliness. This scale is reliable and valid, with strong internal consistency in 
samples of cancer patients (α = .89 - .93) (Deckx et al., 2014), construct validity in measuring the 
adequacy of individuals’ interpersonal relationships, and convergent validity with other measures 
of loneliness (Russell, 1996). In the present study, this scale demonstrated high internal 
consistency reliability (α = .92). 
Perceived Stigma – The Cataldo Lung Cancer Stigma Scale (CLCSS) - Shortened 
Version was used to assess perceived stigma (Carter-Harris & Hall, 2014; Cataldo et al., 2011). 
The CLCSS is a 21-item measure composed of three subscales; Shame and Blame, Social 
Isolation, and Discrimination. Participants were asked to rate the extent to which they agree with 
statements about lung cancer and perceived stigma on a four-point Likert scale from 1 (strongly 
disagree) to 4 (strongly agree). The shortened scale has demonstrated excellent psychometric 
properties, with evidence of strong internal consistency reliability (α = .93) and validity in a 
sample of lung cancer patients (Carter-Harris & Hall, 2014). In the present study, the CLCSS – 
Shortened version demonstrated high internal consistency reliability (α = .90). 
Social Constraint – The Social Constraint Scale (SCS) - Cancer Version is a 15-item self-
report measure assessing perceived barriers to disclosure of cancer-related thoughts or feelings 
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(Lepore, Silver, Wortman, & Wayment, 1996; Lepore & Ituarte, 1999). Respondents were asked 
to rate how frequently they felt socially constrained over the previous month on a four-point 
Likert scale ranging from 1 (never) to 4 (often) (Lepore & Ituarte, 1999; Lepore, 2001). Patients 
were asked to consider people around them when responding to the items. The SCS has 
demonstrated adequate psychometric properties, with moderate convergent validity with other 
validated measures of cancer-related distress and good internal consistency in cancer survivors, 
with Cronbach’s alpha ranging from .88 to .92 (Lepore, 2001). The SCS has also demonstrated 
discriminant validity as compared with a measure of social support received, and predictive 
validity of outcomes including mental health and negative affect. In the present study, this scale 
evidenced high internal consistency reliability (α = .91). 
Negative Social Expectations – The five-item Cancer-related Negative Social 
Expectations Scale was used to measure participants’ social cognitions about cancer and its 
treatment (Adams et al., 2017a). Participants indicated the extent to which they agree with each 
statement on a 6-point Likert scale from ‘strongly disagree’ to ‘strongly agree’. Preliminary 
evidence of internal consistency reliability (α  = .90) and construct validity has been 
demonstrated in a mixed cancer sample (Adams et al., 2017a). In the present study, this scale 
demonstrated adequate internal consistency reliability (α = .77). 
Cancer Self-Efficacy – Cancer self-efficacy was assessed using the 12-item Cancer Belief 
Inventory – Brief Version (CBI-B) (Heitzmann et al., 2011). Participants were asked to rate their 
confidence in their ability to accomplish cancer-related behaviors now or in the near future. Each 
item is rated on a nine-point Likert scale ranging from 1 (not at all confident in ability to 
accomplish behavior) to 9 (totally confident in ability to accomplish behavior). Items were 
summed to create a total score, with higher scores reflecting greater cancer self-efficacy. This 
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measure has demonstrated adequate internal consistency (α = .84 - .88) and validity, and is 
highly correlated with the original scale (CBI-L) (r = .95) (Heitzmann et al., 2011; Merluzzi et 
al., 2001). In the present study, this scale demonstrated adequate internal consistency reliability 
(α = .89). 
Avoidant Coping – The Coping Response Inventory (CRI-Adult) is a self-report measure 
of coping responses (Moos, 1993). Participants completed the six-item Cognitive Avoidance 
subscale to assess avoidant coping. Participants were asked to report the frequency with which 
they engaged in a particular type of coping on a four-point Likert scale of ‘never’, ‘once or 
twice’, ‘sometimes’, and ‘fairly often’. In the current study, participants indicated how often they 
engaged in avoidant coping activity in relation to their cancer and its treatment. The CRI has 
been used with a variety of populations with mental and physical health problems, and the 
subscale used in the current study has demonstrated adequate internal consistency (α  = .60 - .74) 
and validity in measuring avoidant coping (Moos, 1993). In the present study, this subscale 
demonstrated adequate internal consistency reliability (α = .80). 
Quality of Life – The Functional Assessment of Cancer Therapy (FACT-L) is 37-item 
lung cancer-specific measure of well-being. The FACT-L is composed of five subscales, 
including Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional 
Well-Being, and a Lung Cancer Subscale. Respondents indicated the extent to which quality of 
life concerns had impacted them over the past week, rating items on a five-point Likert scale 
ranging from ‘not at all’ to ‘very much’. The five subscale scores were added to compute the 
FACT-L total score, which was the main quality of life outcome variable in the present study. 
Use of the FACT-L total score is advantageous in that includes the four general domains of 
quality of life and incorporates lung cancer-specific information (Cella et al., 2005). The FACT-
  
 
20  
L has demonstrated adequate psychometric properties (a = .87) in lung cancer patients 
(Browning 2009). In the present study, internal consistency reliability for the FACT-L was 
adequate (α = .83). 
Depression – Participants completed the 20-item Center for Epidemiological Studies 
Depression Scale (CES-D) to assess depressive symptoms (Radloff, 1977). Participants denoted 
the frequency with which they had been bothered by specific depressive symptoms over the 
previous week on a 4-point Likert scale ranging from ‘rarely/none of the time’ to ‘most/all of the 
time’. Positively framed items were reverse coded and items were summed to yield a total score 
ranging from 0 to 60, with higher scores indicating greater depressive symptomology. The CES-
D is a valid measure of depressive symptoms in cancer patients with good internal consistency (α 
= .85), test-retest reliability, and construct validity (Hann, Winter, & Jacobsen, 1999). Item 14 on 
the CES-D inquires specifically about loneliness (“I felt lonely”). Due to content overlap with 
the UCLA-V3, CES-D Item 14 was excluded and a total scale score for the 19 remaining items 
was calculated and used in the analyses. The 20-item total scale score for the CES-D is reported 
only to facilitate comparison to published norms. The 20-item and 19-item versions of the CES-
D demonstrated adequate internal consistency reliability in the current study (both α = .89). 
 
Statistical Analyses 
Descriptive statistics (means, standard deviations, frequencies) were computed to 
characterize the sample. In cases (data points n = 74) where participants missed < 20% of items 
on an individual scale, available data for that participant were used to calculate an item-level 
mean value for imputation. Scale scores were subsequently evaluated for normality of their 
distributions. Skew and kurtosis were evaluated using a value of +/- 2; all scale scores fell within 
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these bounds. Cronbach’s alpha was computed for each scale to estimate internal consistency 
reliability.  
Correlational and chi square analyses were used to examine relationships of 
sociodemographic and clinical variables with loneliness. Marital status and performance status 
were significantly (p < .05) associated with loneliness. The associations explored in Aims 1-3 
were evaluated in a regression framework with and without marital status and performance status 
to determine whether the pattern of results remained the same with the control variables. The 
associations tested in Aims 1-3 remained significant (p’s < .05) with the addition of the control 
variables. Therefore, the subsequent analyses were run without the control variables. 
Accordingly, to address Aims 1-3, a series of Pearson’s r correlation coefficients were 
computed. First, we tested whether loneliness at Time 1 was related to depression and quality of 
life (Aim 1). Next, we tested whether perceived stigma, social constraint, negative social 
expectations, cancer self-efficacy, and avoidant coping at Time 1 were related to depression and 
quality of life at Time 1 (Aim 2). Finally, we tested whether perceived stigma, social constraint, 
negative social expectations, cancer self-efficacy, and avoidant coping were related to loneliness 
at Time 1 (Aim 3).  
To address Aim 4, separate models were run evaluating whether loneliness mediated the 
relationships between social-cognitive characteristics (the x variable(s)) and depression and 
quality of life (the y variable(s)). In order to establish mediation, the following conditions must 
be met: 1) the x variable must be correlated with the y variable (c pathway), 2) the x variable 
must be correlated with the mediator, and 3) the mediator must affect the outcome variable 
(Baron & Kenny, 1986). Therefore, the Pearson’s r correlation coefficients calculated in Aims 1-
3 were used to determine whether conditions 1 and 2 of mediation were met. Mediation analyses 
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were limited to situations in which conditions 1 and 2 were met. Next, the y variables were 
entered as the dependent variable in regression equations with each x variable and the mediator 
to determine whether the mediator affected the outcome variable while controlling for the x 
variable (condition 3 of mediation) (Baron & Kenny, 1986). The conditions of complete 
mediation were considered to be met if the relationship between the x and y variable was zero 
when controlling for the mediator. The conditions of partial mediation were considered to be met 
if conditions 1-3 were met, but the relationship between the x and the y variable (c’ pathway) 
was not zero when controlling for the mediator. The degree to which the mediator variable 
accounted for the relationship between the x and y variables was also examined by evaluating the 
size of the c versus the c’ pathway, or the direct effect of x on y (c pathway) versus the effect of 
x on y while accounting for the indirect effect of the mediator (product of path coefficients a and 
b), the c’ pathway.  
First, we examined whether loneliness mediated the relationship between social-cognitive 
variables and depression. Next, we examined whether loneliness mediated the relationship 
between social-cognitive variables and quality of life. We used bias-corrected bootstrapping 
methods (Preacher & Hayes, 2008) with 10,000 bootstrap samples to estimate the indirect effect 
and 95% confidence interval for the indirect effect. When the 95% confidence interval for the 
indirect effect did not include zero, the indirect effect was considered statistically significant. 
Additional reverse mediation models were run evaluating depression and quality of life, 
respectively, as the mediator variables with loneliness as the outcome variable. 
To address Aim 5, hierarchical multiple regression analysis was conducted to explore 
whether loneliness at Time 1 predicted depressive symptoms and quality of life, respectively, at 
Time 2 after accounting for depressive symptoms and quality of life at Time 1. With depressive 
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symptoms at Time 2 serving as the dependent variable, depressive symptoms at Time 1 were 
entered in step 1, followed by loneliness scores at Time 1 in step 2. The same analysis was then 
conducted with quality of life at Time 2 serving as the dependent variable, and quality of life at 
Time 1 entered in step 1, followed by loneliness scores at Time 1 in step 2. Change in R2 was 
used to determine whether loneliness at Time 1 accounted for variance in depressive symptoms 
and quality of life at Time 2 above that accounted for by depressive symptoms and quality of life 
at Time 1. 
A power analysis using G*Power 3.1 indicated that a sample of 84 patients was needed to 
detect a medium effect (r = 0.30) with a Type I error rate of 0.05 (two-tailed) and power of 0.80 
for the univariate correlational analyses addressing Aims 1-3. For the mediational analyses, 
established methods (Fritz and MacKinnon 2007) indicated that a sample size of 115 patients 
was needed to detect a small-medium effect in the α pathway (α = .26) and a medium effect in 
the β pathway (β = .39) with a power of 0.80 when using bias-corrected bootstrapping to test for 
mediation. Finally, power analysis indicated that a sample of 77 was needed to detect a medium 
effect (f2 = 0.15) with a Type I error rate of 0.05 and power of 0.80 in hierarchical multiple 
regression analyses that included three predictors as might be included in the exploratory 
analyses for Aim 5.  Therefore, the current study sought to obtain complete Time 1 data from 
115 participants and complete Time 2 data from 77 participants. Due to difficulties with 
recruitment, with the committee’s consent, recruitment was discontinued once Time 1 data was 
received from 113 participants and Time 2 data was received from 97 participants. 
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RESULTS 
Participant Characteristics 
Participant flow is shown in Figure 2. A total of 1,579 patients were screened for 
eligibility between December 2016 and December 2017. Of that number, 1,423 patients were 
ineligible before consent due to: not having a diagnosis of lung cancer (n=75); not being within 3 
months of beginning systemic or radiotherapy for lung cancer (n=1033); having a history of 
cancer other than lung or non-melanoma skin cancer for which they received treatment in the 
past five years (n=141); not being proficient in English (n=35); not being able to provide consent 
(n=8); not receiving treatment at Moffitt Cancer Center (n=96); being too sick (n=14); or 
becoming deceased prior to approach (n=21). Of the 156 patients approached for study 
participation, 16 refused, and 140 provided written informed consent (90% acceptance rate). Of 
the 140 participants who consented, 113 completed and returned the Time 1 questionnaire (81% 
response rate). Seventy-three percent of patients completed the Time 1 survey in hard copy 
format, while 27% completed the online version. Four patients were deemed to have unusable 
Time 1 data; one became ineligible after consent, and three were missing >20% of the data on 
one or more measures. Of the 109 patients with usable Time 1 data, 97 patients (89%) also had 
usable Time 2 data. Sixty-eight percent of patients who completed the Time 2 survey completed 
the hard copy, while 32% completed the online version. Analyses for Aims 1-4 were conducted 
on the 109 patients with evaluable Time 1 data. Analyses for Aim 5 were conducted using data 
from the 97 patients with evaluable Time 1 and Time 2 data.
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Demographic, clinical, and lifestyle characteristics for the 109 patients included in the 
analyses for Aims 1-4 are shown in Table 2. The majority were non-Hispanic White, with a near 
equal distribution of males (46%) and females (54%). Most patients were married or living with 
a partner (72%), and over half had at least some college education (54%). Participant clinical 
characteristics are shown in Table 3. Participants were diagnosed with either non-small cell 
(84%) or small cell (16%) lung cancer. The majority were diagnosed with late stage disease 
(75%), and patients were an average of 102 days since diagnosis. Current treatment regimens 
included radiation (33%), chemotherapy (74%), immunotherapy (6%), targeted therapy (3%), or 
participation in a clinical trial (17%). Nearly half (48%) of the participants had a performance 
status of 1, indicating restriction in physically strenuous self-care activities. Participant lifestyle 
characteristics are shown in Table 4. Participants reported a moderate level of social engagement 
on the Lubben Social Network Scale, reporting an average score of 3.6 on a 0 to 5 Likert scale 
where higher scores reflect greater social engagement in the past month. Participants included 
never (8%), former (75%), and current (15%) cigarette smokers. A majority reported not 
consuming an alcoholic beverage in the past month (63%). 
Mean scores on the loneliness, depression, quality of life, and social-cognitive measures 
are presented in Table 5. Participants reported a mean score of 33.8 on the UCLA Loneliness 
Scale – Version 3 (SD = 10.4), which represents a low to moderate level of loneliness. 
Participants reported a mean score of 13.7 (SD = 9.4) on the Center for Disease Outcomes – 
Depression Scale, with 38% of participants endorsing a score of >16, indicating significant 
depressive symptomology. Participants reported an average total score of 98.1 (SD = 20.7, 
Median = 100, Range: 43 – 144) on the Functional Assessment of Cancer Therapy-Lung, which 
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is consistent with the median score and range reported in normative data for lung cancer patients 
(Median = 95, Range: 44 – 135) (Cella et al., 2005).  
Participants (n = 140) were compared to non-consenters (n = 16) on demographic 
characteristics; there were no significant differences between groups (p’s > .05).  Participants 
who completed the Time 1 questionnaire (n = 113) were compared to those who did not (n = 27). 
Completers were more likely to be White than non-White (χ2 = 3.91, p < .05). 
 
Analyses Related to Aims 1, 2, and 3 
Correlations of loneliness with depression and quality of life are shown in Table 6. As 
hypothesized, loneliness was associated with greater depressive symptomology (r = .44) and 
worse quality of life (r = -.59) (p values < .001). 
Correlations between social-cognitive characteristics and depression and quality of life 
are shown in Table 7. As hypothesized, greater lung cancer-related stigma, social constraint, 
cancer-related negative social expectations and avoidant coping, and lesser beliefs about one’s 
ability to cope with cancer were associated with greater depressive symptomology and worse 
quality of life (all p values < .001).  
Correlations of loneliness with social-cognitive characteristics are shown in Table 8. As 
hypothesized, greater lung cancer-related stigma, social constraint, cancer-related negative social 
expectations and avoidant coping, and lesser beliefs about one’s ability to cope with cancer were 
significantly correlated with loneliness (all p values < .001).  
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Analyses Related to Aim 4 
Ten mediation models were run to examine loneliness as a mediator of the relationships 
between social-cognitive variables and depression and quality of life, respectively. The social-
cognitive variables were treated as the independent variables, loneliness as the mediator, and 
depression and quality of life as the dependent variables. Results of analyses for Aims 1, 2, and 3 
demonstrated that all social-cognitive variables, loneliness, and depression and quality of life 
were significantly correlated, so all ten models were run. Bootstrapped estimates and 95% 
confidence intervals for the indirect effects in the mediation models are shown in Table 9. 
Loneliness partially mediated the relationship between lung cancer-related stigma, social 
constraint, cancer-related negative social expectations and avoidant coping with depressive 
symptoms, as evidenced by 95% confidence intervals for the indirect effect that do not include 
zero. Loneliness did not mediate the relationship between beliefs about one’s ability to cope with 
cancer and depressive symptoms (95% CI: -.24 to .02). Additionally, loneliness partially 
mediated the relationship between lung cancer-related stigma, social constraint, cancer-related 
negative social expectations, avoidant coping, and beliefs about one’s ability to cope with cancer 
with quality of life, as indicated by 95% confidence intervals for the indirect effect that do not 
include zero.  
The mediation models are visually presented in Figures 3a-j, with standardized beta 
weights for the a, b, c, and c’ pathways shown. Standardized effects sizes for the α pathway were 
medium in size (Range: β = .35 to .59) and small-medium in size for the b pathway (Range: β = 
.27 to .48). The c pathway represents the direct effect of each social-cognitive variable on 
depressive symptoms or quality of life, respectively. The c’ path represents the effect of each 
social-cognitive variable on depressive symptoms or quality of life when loneliness is added as a 
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mediator variable. As an example, Figure 3a depicts the model of loneliness as a mediator of the 
relationship between lung cancer-related stigma and depressive symptoms. The size of the β 
weight is reduced when loneliness is added as a mediator (c pathway = -.40, p <.001; c’ pathway 
= -.22, p <.05), consistent with the significant indirect effect in the bootstrap analyses and 
evidence of loneliness as a partial mediator of the relationship between lung cancer-related 
stigma and depressive symptoms. Figure 3e depicts the model of loneliness as a mediator of the 
relationship between beliefs about ones ability to cope with cancer and depressive symptoms. 
The size of the β weight is not reduced appreciably (c pathway = -.60, p <.001; c’ pathway = -
.50, p <.001), consistent with the non-significant indirect effect of the bootstrap analyses and 
evidence that loneliness does not mediate the relationship between beliefs about ones ability to 
cope with cancer and depressive symptoms.  
Additional mediation analyses were performed in which the proposed mediator, 
loneliness, was entered as the dependent variable, and the dependent variables, depression and 
quality of life, were entered separately as the mediator variable. The results of these reverse 
mediation analyses, with bootstrapped estimates and 95% confidence intervals for the indirect 
effect, are shown in Table 10. Depressive symptoms partially mediated the relationship between 
lung cancer-related stigma, social constraint, cancer-related negative social expectations and 
avoidant coping with loneliness. Depressive symptoms did not mediate the relationship between 
beliefs about one’s ability to cope with cancer and loneliness (95% CI: -.29 to .04). Quality of 
life partially mediated the relationship between lung cancer-related stigma, social constraint, 
cancer-related negative social expectations, avoidant coping, and beliefs about one’s ability to 
cope with cancer with loneliness. 
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Analyses Related to Aim 5 
Descriptive statistics for loneliness, depression, and quality of life at Time 2 are shown in 
Table 11. Two hierarchical multiple regression analyses were conducted to determine the relative 
contribution of loneliness at Time 1 in predicting depressive symptoms and quality of life, 
respectively, at Time 2 after accounting for depressive symptoms and quality of life at Time 1. 
Data were evaluated for multicollinearity (variance inflation factor (VIF) of > 4); no variables 
exceeded this threshold. 
The results examining depressive symptoms at Time 2 as the dependent variable are 
shown in Table 12. Depressive symptoms at Time 1 accounted for 17% of the variance in 
depressive symptoms at Time 2 (β = .43, t = .98, p < .001). Loneliness at Time 1 accounted for 
an additional 14% of the variance in depressive symptoms at Time 2 (β = .38, t = 4.4, p < .001) 
beyond that accounted for by depressive symptoms at Time 1. The results of the model 
examining quality of life at Time 2 as the dependent variable are presented in Table 13. Quality 
of life at Time 1 accounted for 46% of the variance in quality of life at Time 2 (β = .68, t = 9.0, p 
< .001). The addition of loneliness at Time 2 did not significantly change the variance accounted 
for (ΔR2 = -.01, R2 = .45).  
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DISCUSSION 
The purpose of the current study was to investigate the relationship of loneliness to 
depressive symptoms and quality of life in a sample of lung cancer patients. The study also 
sought to identify social-cognitive variables associated with loneliness and to explore the role of 
loneliness in mediating relationships between these variables and depressive symptoms and 
quality of life. Finally, the study examined whether loneliness predicted change over time in 
depressive symptoms and quality of life. 
The results of the current study confirmed a priori hypotheses. As predicted, loneliness 
was positively correlated with depressive symptoms and negatively correlated with quality of 
life. In addition, loneliness was correlated with social-cognitive variables in the expected 
directions and social-cognitive variables were related to depressive symptoms and quality of life 
in the expected directions. 
 Mediation analyses yielded evidence for partial mediation, with loneliness mediating the 
relationships of social-cognitive variables with depressive symptoms and quality of life for nine 
of the ten models tested, as evidenced by significant indirect effects of the bootstrap analyses and 
appreciable drops in size of the c versus the c’ pathway, signifying that the addition of loneliness 
to the equation helped to explain the relationship between the social-cognitive variable of interest 
and depressive symptoms or quality of life, respectively. The exception was findings showing 
that loneliness did not mediate the relationship between beliefs about one’s ability to cope with 
cancer and depressive symptoms. It should be noted that reverse mediation analyses also 
provided support for partial mediation in the same nine models when depressive symptoms and 
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quality of life were treated as the mediators and loneliness was treated as the dependent variable. 
Given that the variables of interest were at least moderately correlated with each other as 
demonstrated in Aims 1-3, evidence in support of both forward and reverse partial mediation is 
not surprising. Finally, exploratory analyses showed that loneliness at Time 1 predicted 
additional variance in depressive symptoms at Time 2 after accounting for depressive symptoms 
at Time 1. However, loneliness at Time 1 did not account for additional variance in quality of 
life at Time 2 after accounting for quality of life at Time 1.  
The mean score on the UCLA Loneliness Scale in the current sample of lung cancer 
patients (M=33.8) was lower than the weighted mean score reported in a meta-analysis of 
loneliness in mixed cancer samples (M = 38.26) (Deckx, van den Akker, & Buntinx, 2014). This 
might be due to patients in the current study being relatively close to the time of diagnosis. 
Research examining the trajectories of perceived social support in breast and colorectal cancer 
has demonstrated that patients report an increase in the availability of support around the time of 
cancer diagnosis, which then declines over time (Haviland et al., 2017; Thompson, Rodebaugh, 
Perez & Jeffe, 2013). Interestingly, loneliness scores in the current study increased by nearly 2 
points from the Time 1 to Time 2 assessment (T2 M = 35.5). This is consistent with the pattern 
of results observed in the meta-analysis, in which patients who were further from diagnosis 
endorsed significantly more feelings of loneliness than those who were closer to the time of 
diagnosis (Deckx, van den Akker, & Buntinx, 2014).  Over one third of patients in the current 
sample reported a score of > 16 on the CES-D, a cutoff score which is commonly used to 
indicate the presence of clinically significant depressive symptoms. This rate is higher than what 
is found in general cancer samples, where rates of depression range from 8 – 24% depending on 
clinical characteristics and how symptoms are assessed (Krebber et al., 2014), but consistent with 
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higher reported rates of depression in lung cancer samples (Gonzalez & Jacobsen, 2012; Cataldo, 
Jahan, & Pongquan, 2012; Zabora, BrintzenhofeSzoc, Curbow, Hooker, & Piantadosi, 2001). 
Quality of life in the current study was consistent with normative data collected from a sample of 
lung cancer patients (Cella et al., 2005), with a median and range of FACT-L values similar to 
those found in the current study. Quality of life in our sample was higher than baseline values for 
a sample of lung cancer patients with recently diagnosed metastatic disease (Temel et al., 2010), 
which may reflect differences in clinical factors between the samples.  
The current study extends to lung cancer patients previous findings demonstrating a 
positive association between loneliness and depression in mixed and breast cancer samples 
(Jaremka et al., 2014; Adams et al., 2017a). In the current study, loneliness and depressive 
symptoms were moderately correlated (r = .44), which is consistent with previous work that has 
established loneliness and depression as distinct constructs worthy of independent investigation 
(Cacioppo et al., 2006b; Jaremka et al., 2014; Russell, Cutrona, Rose, & Yurko, 1984; Russell, 
1996); Weeks, Michela, Peplau, & Bragg, 1980). Additionally, the current study extends findings 
from a longitudinal study of older adults examining the relationship between loneliness and 
depression over time (Cacioppo, Hawkley, & Thisted, 2010), in that our study similarly found 
that loneliness predicts variance in depressive symptoms over time after accounting for 
depressive symptoms at baseline.  
Similarly, loneliness has been correlated with worse quality of life in breast and mixed 
cancer samples (Adams et al., 2017a; Boer, Elving, & Seydel, 1998; Deckx et al., 2013; 
Fanakidou et al., 2018), but the relationship between the two has not been examined specifically 
in lung cancer patients to date. The strong negative correlation between loneliness and quality of 
life in the current study (r = -.59) is clinically meaningful in that both loneliness and quality of 
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life have been linked to important outcomes in cancer patients, including overall morbidity and 
mortality (Hawkley & Cacioppo, 2003, 2010; Vodermaier, Lucas, Linden & Olson, 2017).  
Unlike findings for depressive symptoms, we did not find that loneliness predicted quality of life 
over time after accounting for quality of life at baseline. Future research should seek to 
disentangle the longitudinal relationships between these constructs in lung cancer samples.  
The current study addressed an important gap in the literature by examining the 
relationship of social-cognitive variables with important clinical outcomes in lung cancer 
patients. Lung cancer patients are an understudied population in psychosocial oncology research 
and previous studies have focused primarily on the relationship of demographic, disease, and 
treatment variables with depression and quality of life. The current study extends to lung cancer 
patients findings on the relationship of social constraint and cancer-related negative social 
expectations with depression and quality of life from mixed cancer samples (Adams et al., 2015, 
2017a, 2017b; Heitzmann et al., 2011). Findings regarding the relationships of cancer-related 
negative social expectations and beliefs about one’s ability to cope with cancer with depressive 
symptoms and quality of life are generally consistent with those found in general cancer samples 
(Adams et al., 2017a; Heitzmann et al., 2011; Philip, Merluzzi, Zhang, & Heitzmann, 2013). The 
relationship between beliefs about ability to cope with cancer and quality of life was particularly 
strong (r = .72) in the current study whereas it was found to be moderate (r= .43) in mixed cancer 
samples (Heitzmann et al., 2011). It is possible that this is something unique to lung cancer, 
whereby patients who are able to maintain cancer-related self-efficacy in the face of a disease 
with a generally poor prognosis experience better quality of life. Consistent with this view, a 
recent study of patients with advanced lung cancer within three months of starting therapy found 
that self-efficacy was the most prominent predictor of quality of life (Liao et al., 2014).  
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The current study aligns with previous work that has reported a positive correlation 
between cancer-related stigma and depression (Brown Johnson et al., 2014; Cataldo et al., 2011, 
Cataldo, Jahan, & Pongquan, 2012; Else-Quest, LoConte, Schiller, & Hyde, 2009; Gonzalez & 
Jacobsen, 2012), and a negative correlation between cancer-related stigma and quality of life in 
lung cancer patients (Brown Johnson et al., 2014; Cataldo et al., 2011, Cataldo, Jahan, & 
Pongquan, 2012; Chambers et al., 2012, 2015) Work by Cataldo and colleagues has posited that 
cancer-related stigma in lung cancer patients can cause fear of social rejection in patients and 
negatively influence social relationships by limiting social support, which may be associated 
with depression and worse quality of life. This conceptualization is also aligned with the Social-
Cognitive Processing Model, which suggests that negative health outcomes occur when an 
individual feels they are unable to express their thoughts and emotions related to a stressor with 
those around them (Badr & Taylor, 2006; Lepore & Revenson, 2007).  
The current study provided further support for the negative impact of social constraint on 
cancer patient outcomes, specifically depressive symptoms (r = .41) and worse quality of life (r = 
-.45) (Adams et al., 2015, 2016b; Cordova, Cunningham, Carlson, & Andrykowski, 2001; 
Lepore & Revenson, 2007). While avoidant coping was associated with depressive symptoms 
and quality of life in the anticipated directions (Gonzalez & Jacobsen, 2012; Kershaw, 
Northouse, Kritpracha, Schafenacker & Mood, 2004; Nipp et al., 2016), we found a stronger 
correlation between avoidant coping and depressive symptoms (r = .59) than has been previously 
reported in a lung cancer sample (r = .36) (Gonzalez & Jacobsen, 2012). This may be attributable 
to differences in the study samples, as patients in the current study were an average of 3.5 
months post-diagnosis while patients in the Gonzalez & Jacobsen study were an average of 18 
months post-diagnosis, such that patients the in the current study may still have been processing 
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receipt of the cancer diagnosis and treatment and utilizing avoidant coping strategies, such as 
wishing that the problem would go away.  
The current study is novel for its examination of relationships between social-cognitive 
variables and loneliness. While some of these social-cognitive variables have been explored in 
cancer samples, few have been examined solely in lung cancer patients. In addition, previous 
research has not looked at these variables together to allow for comparison of the strength of 
relationships with loneliness. Findings were generally in line with the hypothesized direction 
based on social-cognitive theory and previous research (Adams et al., 2017a; Lepore, 2001; 
Mosher et al., 2012). Specifically, findings confirmed a positive association between loneliness 
and cancer-related negative social expectations in lung cancer patients, as has been reported in a 
diverse cancer sample (Adams et al., 2017a). This is consistent with the idea that lonelier people 
may view the world as more socially threatening, expect more negative social interactions and 
therefore experience them as such (Adams et al., 2017a; Cacioppo et al., 2006b; Hawkley & 
Cacioppo, 2010). The current study provides initial data on the relationship of lesser beliefs 
about one’s ability to cope with cancer and more avoidant coping with loneliness in lung cancer 
patients. Social constraint has been correlated with loneliness in cancer survivors (Mosher et al., 
2012), a finding this study extends to lung cancer patients. Findings regarding the relationship 
between lung cancer-related stigma and loneliness are particularly novel. Our study extends 
beyond the previously reported relationships of perceived stigma with greater depressive 
symptoms (Brown Johnson et al., 2014; Cataldo et al., 2011, Cataldo, Jahan, & Pongquan, 2012; 
Else-Quest, LoConte, Schiller, & Hyde, 2009; Gonzalez & Jacobsen, 2012) and worse quality of 
life (Brown Johnson et al., 2014; Cataldo et al., 2011, Cataldo, Jahan, & Pongquan, 2012; 
Chambers et al., 2012, 2015) in lung cancer patients to show that stigma is also linked to 
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loneliness. Additionally, results of mediation analyses indicated that loneliness partially mediates 
the relationship between stigma and depression and quality of life. Research on HIV-infected 
individuals has demonstrated this pattern of results, where loneliness mediates the relationship 
between HIV-related stigma and depressive symptoms (Fekete, Williams & Skinta, 2018). Our 
findings implicate a reduction in loneliness as the mechanism by which intervening with 
perceived stigma may help to improve lung cancer patients’ psychosocial outcomes, such as 
lesser depressive symptoms and better quality of life. 
Analyses evaluating loneliness as a mediator variable to explain the relationship between 
other social-cognitive factors with depressive symptoms and quality of life demonstrated 
evidence of partial mediation, aside from beliefs about ability to cope with cancer. We did not 
find evidence for loneliness as a mediator between beliefs about one’s ability to cope with cancer 
with depressive symptoms, suggesting that other factors may have more explanatory value than 
loneliness when looking at this relationship. This may also be a product of the strong 
independent correlation between self-efficacy and depression. A study of coping self-efficacy 
and depression in cancer survivors found that cancer self-efficacy was a significant independent 
predictor of depression, while social support was not a significant predictor (Philip, Merluzzi, 
Zhang, & Heitzmann, 2013). This suggests that internal perceptions of one’s inability to cope 
with a stressor may be strongly related to depression such that the availability of perceived or 
actual social resources has a negligible influence. Previous work has demonstrated evidence of 
loneliness as a partial mediator of the relationship between social constraint and distress as well 
as between emotional expression and depressive symptoms in cancer samples, consistent with 
our finding in support of loneliness as a mediator between social constraint and depressive 
symptoms (Marroquin, Czamanski-Cohen, Weihs & Stanton, 2016; Mosher et al., 2012). 
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However, the ability to draw definitive conclusions about loneliness as a mediator and the 
direction of relationships among these variables is precluded by the use of cross-sectional data 
and the results of reverse mediation analyses, which also suggest that depressive symptoms and 
quality of life might act as mediator variables between social-cognitive factors and loneliness.  
 Strengths of the current study include the novel application of a social-cognitive model to 
understanding factors contributing to depressive symptoms and quality of life in lung cancer 
patients. In addition, the demographic, clinical, and lifestyle characteristics of the study sample 
are generally consistent with the population of lung cancer patients seen in major treatment 
centers. This pattern includes a roughly even division of men and women, a typical distribution 
of never versus ever smokers, and an approximately 6:1 ratio of patients with NSCLC to SCLC 
(American Cancer Society, 2018).  
The study does, however, possess several limitations. First, the study sample was 
relatively homogenous with regard to racial and ethnic representation, which may limit the 
generalizability of findings to more diverse lung cancer populations. Second, shared method 
variance in the measurement of study variables should be considered based on the use of self-
report measures. Third, analyses were performed primarily on cross-sectional data. Mediation 
analyses conducted on data from a single time point limits the ability to draw conclusions 
regarding the directionality of relationships in these models. Indeed, reverse mediation analyses 
also suggested the possibility of depression and quality of life as mediator variables, which 
precludes the ability to deduce that loneliness acts as the sole mediator variable in these 
relationships. Longitudinal research designs should be employed to better explore the pattern of 
relationships among these variables over time. Fourth, even though analyses related to the last 
study aim were conducted using longitudinal data, the two time points were relatively close 
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together, which limited the ability to capture change over time. Finally, the timing of study 
participation may have influenced the pattern of results. All the patients in the current study were 
within three months of beginning systemic or radiation therapy for lung cancer, and were on 
average 3.5 months post-diagnosis. Since patients were close to diagnosis and all were on active 
treatment, it is possible that they may have benefitted from the bolus of support that some 
patients receive in the period directly after diagnosis.  
With regard to future research, study results provide support for expanding the 
assessment of loneliness in clinical research and practice. Loneliness has received increasing 
attention as a public health problem in the context of the current age shift in the population. 
Given that the majority of cancers occur in older adults, continued study of loneliness and 
potentially modifiable factors related to loneliness in cancer patients and survivors is warranted. 
Findings also support developing and evaluating interventions targeted at social-cognitive factors 
as a means of reducing loneliness and thereby reducing depressive symptoms and improving 
quality of life in people with lung cancer. For example, cognitive-behaviorally based therapies 
designed to change maladaptive social cognitions and increase patients’ self-efficacy to 
communicate effectively about cancer-related feelings and experiences may help to minimize 
social constraint, reduce perceptions of being stigmatized, and alter cancer-related negative 
social expectations (Masi, Chen, Hawkley, & Cacioppo, 2011). Patients may, in turn, engage in 
more social interactions and feel more satisfied with their interactions, thus reducing feelings of 
loneliness and improving outcomes.  
An additional direction for future research is to focus greater attention on model 
development and evaluation. Using the social-cognitive model to explain the relationships 
between these variables and loneliness in the context of lung cancer was supported by prior 
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research. However, the general structure of the mediation models in the current study may be an 
oversimplification as suggested by the results of the reverse mediation analyses that were 
conducted. Other recent studies also suggest that the relationships among social-cognitive 
variables are complex. For example, in a study of long-term breast cancer survivors, avoidant 
coping and self-efficacy for symptom management were found to mediate the relationship 
between social constraint and self-efficacy for symptom management (Adams et al., 2016b). 
Another recent intervention trial identified multiple mediators of an internet-based psychosocial 
intervention for women with breast cancer, including loneliness, coping self-confidence, and 
social support (Cleary & Stanton, 2015). These examples illustrate how variables used in the 
current mediation models may interact in more complex ways. Use of advanced statistical 
techniques, such as structural equation modeling and path analysis, with larger samples can assist 
with the further exploration of the relationships among variables. 
 In summary, results from the present study suggest that consideration of loneliness is 
important in order to understand differences in depression and quality of life in cancer 
populations, particularly in lung cancer patients. Beyond its direct impact on clinically relevant 
outcomes, the experience of loneliness may be the mechanism by which social-cognitive factors 
influence depression and quality of life. Investigation of the relationship between stigma and 
loneliness in the context of lung cancer is particularly novel and warrants further exploration. 
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Table 2. Sociodemographic Characteristics (N=109) 
 
 M (SD) [Range] or N (%) 
Age 65.5 (9.4) [40 – 83] 
Gender   
Male 50 (46%) 
Female 59 (54%) 
Ethnicity   
Spanish/Hispanic/Latino 5 (5%) 
Not Spanish/Hispanic/Latino 104 (95%) 
Race   
American Indian or Alaska Native 1 (.9%) 
Asian 1 (.9%) 
Black or African American 4 (4%) 
White 103 (94%) 
Marital Status   
Married or living with partner 78 (72%) 
Single 8 (7%) 
Divorced 14 (13%) 
Separated 1 (.9%) 
Widowed 8 (7%) 
Completed Education   
Less than 12 years 16 (15%) 
High school graduate 27 (25%) 
Trade school 7 (6%) 
Some college 33 (30%) 
College graduate 16 (15%) 
Post-graduate degree 10 (9%) 
Current Employment  
Working  
Full time at job 18 (17%) 
Part time at job 2 (2%) 
On Leave  
With pay 8 (7%) 
Without pay 7 (6%) 
Not Employed  
Disabled 9 (8%) 
Retired 56 (52%) 
Homemaker 7 (6%) 
Missing  2 (2%) 
Religious Affiliation (belong to church, 
temple other religious group) 
 
No 60 (55%) 
Yes 47 (43%) 
   Missing  2 (2%) 
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Table 3. Clinical Characteristics 
 M (SD) [Range] or N (%) 
Lung Cancer Type  
NSCLC  92 (84%) 
SCLC  17 (16%) 
NSCLC Type  
Adenocarcinoma 63 (68%) 
Squamous Cell Carcinoma 22 (24%) 
Large Cell Carcinoma 1 (1%) 
Large Cell Neuroendocrine Tumor 4 (4%) 
Unknown 2 (2%) 
AJCC Stage  
I 4 (4%) 
II 15 (16%) 
III 33 (36%) 
IV 40 (44%) 
SCLC Stage  
Limited Stage 8 (47%) 
Extensive Stage 9 (53%) 
Surgery  
  Yes 29 (27%) 
  No 80 (73%) 
Type of Procedure  
Wedge Resection 4 (14%) 
Segmentectomy 2 (7%) 
Lobectomy 19 (66%) 
Pneumonectomy 1 (3%) 
Unknown 3 (10%) 
Time Since Surgery (days) 214 (358) [50 - 1730]  
Median = 96 
Current Treatment  
Radiation 36 (33%) 
Chemotherapy 81 (74%) 
Immunotherapy 7 (6%) 
Targeted Therapy 3 (3%) 
Clinical Trial 18 (17%) 
Previous Treatment  
Radiation 15 (14%) 
Chemotherapy 4 (4%) 
Immunotherapy 0 (0%) 
Targeted Therapy 0 (0%) 
Clinical Trial 1 (.9%) 
Brain Metastases  
Yes 14 (13%) 
No 95 (87%) 
Radiation for Brain Metastases  
  
 
63  
Yes 9 (64%) 
No 5 (36%) 
Time Since Diagnosis (days)  102 (58.4) [18 – 370]  
Median = 92 
1st Course of Lung Cancer Treatment   
Yes 105 (96%) 
No 4 (4%) 
Previous Cancer Diagnosis (non-lung, 
non-melanoma skin) 
 
Yes 15 (14%) 
No 94 (86%) 
Performance Status  
(0) Fully Active  27 (25%) 
(1) Restricted in physically strenuous 
self-care 
52 (48%) 
(2) Ambulatory and capable self-care, but 
unable to carry out work activities 
20 (18%) 
(3) Capable only limited self-care 7 (6%) 
(4) Completely disabled 1 (.9%) 
Missing N=2 2 (2%) 
NSCLC= Non-small cell lung cancer, SCLC= Small cell lung cancer, AJCC = American 
Joint Committee on Cancer 
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Table 4. Lifestyle Characteristics 
 M (SD) [Range] or N (%) 
Social Network 
Lubben Social Network Scale 19.8 (6.0) [3 – 30] 
   Average contacts friends/family past 
month 
3.6 (1.0) [0 – 5] 
Smoking History 
Smoked >100 cigarettes in lifetime  
Yes 100 (92%) 
No 9 (8%) 
Average # cigarettes/day 24.9 (14.7) [1-70] 
Median=20 
Average number of years smoked  34.0 (13.6) [0-65] 
Smoking Status  
Never Smokers 9 (8%) 
Former Smokers  82 (75%) 
Current Smokers 16 (15%) 
Missing 2 (2%) 
Average time quit (former smokers) 
(years) 
12.8 (13.7) [1 month – 56 years] 
Alcohol 
Consumed alcoholic beverage in past 
month? 
 
Yes 40 (37%) 
No 69 (63%) 
If yes, average number of drinks in past 
month  
 
1-3x/month 18 (45%) 
1-3x/week 9 (22%) 
4-6x/week 7 (18%) 
1x/day 2 (5%) 
2x/day 4 (10%) 
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Table 5. Loneliness, Social-Cognitive Characteristics, Depression, and Quality of Life  
 M (SD) [Range] or N (%) 
Loneliness  
UCLA Loneliness Scale (UCLA V3) 33.8 (10.4) [20-64] 
Low (20-34) 61 (56%) 
Moderate (35-49) 37 (34%) 
Moderately High (50-64) 11 (10%) 
High (65+) 0 (0%) 
Social-Cognitive Characteristics  
Cataldo Lung Cancer Stigma Scale (CLCSS) 70.0  (8.5) [44-84] 
Social Constraint Scale (SCS) 24.8  (7.8) [15-52] 
Cancer-Related Negative Social Expectations (CNSES) 15.4  (6.1) [5-28] 
Cancer Belief Inventory – Brief (CBI-B) 88.1 (14.6) [46–108] 
Coping Responses Inventory – Avoidant Coping 
Subscale (CRI-Avoidant) 
5.6 (4.0) [0-18] 
Depression  
Center for Epidemiologic Studies Depression Scale 
(CES-D) 
13.7 (9.4) [0-48] 
CES-D >16 41 (38%) 
Quality of Life  
Functional Assessment of Cancer Therapy – Lung 
(FACT-L) 
98.1 (20.7) [43-134]  
Median = 100.2 
Physical Well-being (PWB) 18.8 (6.1) [1-28] 
Social/Family Well-being (SWB) 24.7 (3.9) [8-28] 
Emotional Well-being (EWB) 18.6 (4.6) [2-24] 
Functional Well-being (FWB) 16.9 (6.6) [4-28] 
Lung Cancer Subscale (LCS) 19.2 (5.1) [3-28] 
FACT-G 79.0 (17.2) [33-108] 
Treatment Outcome Index (TOI) 54.8 (15.4) [23-82] 
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Table 6.  Correlations of Loneliness with Depression and Quality of Life (QOL) 
 
 Depression QOL 
Loneliness .44*** -.59*** 
* p < .05, **p < .01, *** p < .001 
 
 
 
 
Table 7.  Correlations of Social-Cognitive Characteristics with Depression and  
Quality of Life (QOL) 
 
Social-Cognitive Characteristic Depression QOL 
Lung Cancer-related Stigma -.40***  .51*** 
Social Constraints .41*** -.45*** 
Cancer-related Negative Social 
Expectations 
.46*** -.44*** 
Beliefs about Ability to Cope with 
Cancer 
-.60***   .72*** 
Avoidant Coping .59*** -.54*** 
* p < .05, **p < .01, *** p < .001 
 
 
 
 
Table 8. Correlations of Loneliness with Social-Cognitive Factors 
 
Social-Cognitive Characteristic Loneliness 
Lung Cancer-related Stigma -.59*** 
Social Constraints .45*** 
Cancer-related Negative Social 
Expectations 
.43*** 
Beliefs about Ability to Cope with 
Cancer 
         -.49*** 
Avoidant Coping           .35*** 
* p < .05, **p < .01, *** p < .001 
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Table 9: Bootstrapped Estimates and Confidence Intervals for Tests of the Indirect Effects of 
Loneliness as a Mediator Variable 
 
 
 
  
IV Path c (IV to 
DV) 
Total effect B 
(SE) 
Effect of IV 
on M (a)  
B (SE) 
Effect of M 
on DV (b) B 
(SE) 
Direct effects 
(c’)  
B (SE) 
Indirect 
effect  
(a x b)  
Indirect 
effect 
(a x b)  
95% CI 
 DV = Depression (CES-D) 
CLCSS -.42 (.09)*** -.73 (.10)*** .27 (.09)** -.23 (.11)* -.19 -.33 to -.05 
SCS .47 (.10)*** .59 (.12)*** .28 (.08)*** .30 (.11)** .14 .04 to .28 
CNSES .68 (.13)*** .73 (.15)*** .25 (.08)** .49 (.13)*** .13 .02 to .27 
CRI 1.31 (.17)*** .91 (.24)*** .23 (.07)** 1.10 (.18)*** .09 .02 to .20 
CBI-B -.36 (.05)*** -.35 (.06)*** .17 (.07)* -.30 (.05)*** -.10 -.24 to .02 
 DV = Quality of Life (FACT-L) 
CLCSS 1.24 (.20)*** -.73 (.10)*** -.87 (.19)*** .61 (.23)* .26 .14 to .39 
SCS -1.20 (.23)*** .59 (.12)*** -.95 (.17)*** -.64 (.23)** -.21 -.34 to -.11 
CNSES -1.49 (.30)*** .73 (.15)*** -.97 (.17)*** -.79 (.29)** -.21 -.34 to -.10 
CRI -2.79 (.42)*** .91 (.24)*** -.90 (.15)*** -1.97 (.39)*** -.16 -.27 to -.07 
CBI-B 1.01 (.10)*** -.35 (.06)*** -.62 (.14)*** .80 (.10)*** .15 .07 to .26 
*Unstandardized regression coefficients reported. IV = independent variable; DV = dependent 
variable; M = mediator variable; CI = confidence interval; CES-D = Center for Epidemiologic Studies 
Depression Scale; FACT-L = Functional Assessment of Cancer Therapy – Lung; CLCSS = Cataldo 
Lung Cancer Stigma Scale; SCS = Social Constraint Scale; CNSES = Cancer-related Negative Social 
Expectations Scale; CRI = Coping Resources Inventory - Avoidant Coping Subscale; CBI-B = Cancer 
Beliefs Inventory – Brief  
* p < .05, ** p < .01, *** p < .001 
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Table 10. Bootstrapped Estimates and Confidence Intervals for Tests of Indirect Effects of 
Depression and Quality of Life as Mediator Variables and Loneliness as the Dependent 
Variable (Reverse Mediation) 
 
 
 
 
IV Path c (IV to 
DV) 
Total effect β 
Effect of 
IV on M 
(a) β 
Effect of 
M on DV 
(b) β 
Direct 
effects 
(c’) β 
Indirect 
effect 
(a x b) 
Indirect 
effect 
(a x b) 
95% CI 
 DV = Loneliness, Mediator = Depression (CES-D) 
CLCSS -.59*** -.40*** .24** -.49*** -.10 -.23 to -.02 
SCS .45*** .41*** .31*** .32*** .13 .04 to .26 
CNSES .43*** .46*** .31** .28** .14 .03 to .28 
CRI .35*** .59*** .36** .14 .21 .06 to .38 
CBI-B -.49*** -.60*** .23* -.35** -.14 -.29 to .04 
 DV = Loneliness, Mediator = Quality of Life (FACT-L) 
CLCSS -.59*** .51*** -.38*** -.40*** -.19 -.34 to -.09 
SCS .45*** -.45*** -.48*** .23** .22 .12 to .34 
CNSES .43*** -.44*** -.49*** .21* .22 .11 to .34 
CRI .35*** -.54*** -.56*** .05 .30 .19 to .43 
CBI-B -.49*** .72*** -.48*** -.14 -.35 -.54 to -.17 
*Unstandardized regression coefficients reported. IV = independent variable; DV = dependent 
variable; M = mediator variable; CI = confidence interval; CES-D = Center for Epidemiologic 
Studies Depression Scale; FACT-L = Functional Assessment of Cancer Therapy – Lung; CLCSS 
= Cataldo Lung Cancer Stigma Scale; SCS = Social Constraint Scale; CNSES = Cancer-related 
Negative Social Expectations Scale; CRI = Coping Resources Inventory - Avoidant Coping 
Subscale; CBI-B = Cancer Beliefs Inventory – Brief  
* p < .05, ** p < .01, *** p < .001 
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Lung-cancer 
related stigma 
Loneliness 
Depressive 
Symptoms 
α =
 - .5
9**
* 
b = .31** 
c’ = -.22* 
c = -.40*** 
Figure 3a. Loneliness as a Mediator of the Relationship between Lung Cancer-related 
Stigma and Depressive Symptoms 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
Social constraints 
Loneliness 
Depressive 
Symptoms 
α =
 .45
***
 
b = .32*** 
c’ = .26**  
c = .41*** 
Figure 3b. Loneliness as a Mediator of the Relationship between Social Constraints and 
Depressive Symptoms 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
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Cancer-related 
negative social 
expectations 
Loneliness 
Depressive 
Symptoms 
α =
 .43
***
 
b = .30** 
c’ = .34*** 
c = .46*** 
Figure 3c. Loneliness as a Mediator of the Relationship between Cancer-related Negative 
Social Expectations and Depressive Symptoms 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
Avoidant coping 
Loneliness 
Depressive 
Symptoms 
α =
 .35
***
 
b = .27** 
c’ = .50*** 
c = .59*** 
Figure 3d. Loneliness as a Mediator of the Relationship between Avoidant Coping and 
Depressive Symptoms 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
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Beliefs about 
ability to cope 
with cancer 
Loneliness 
Depressive 
Symptoms 
α =
 -.4
9**
* 
b = .20* 
c’ = -.50*** 
c = -.60*** 
Figure 3e. Loneliness as a Mediator of the Relationship between Beliefs about Ability to 
Cope with Cancer and Depressive Symptoms 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
Lung cancer-
related stigma 
Loneliness 
Quality of Life 
α =
 -.5
9**
* 
b = -.44*** 
c’ = .25* 
c = .51*** 
Figure 3f. Loneliness as a Mediator of the Relationship between Lung Cancer-related 
Stigma and Quality of Life 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
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Social constraints 
Loneliness 
Quality of Life 
α =
 .45
***
 
b = -.48*** 
c’ = -.24** 
c = -.45*** 
Figure 3g. Loneliness as a Mediator of the Relationship between Social Constraints 
and Quality of Life 
Standardized coefficients shown. c pathway = total effect of the independent variable 
on the dependent variable; c’ pathway = effect of the independent variable on the 
dependent variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
Cancer-related 
negative social 
expectations 
Loneliness 
Quality of Life 
α =
 .43
***
 
b = -.48*** 
c’ = -.23** 
c = -.44*** 
Figure 3h. Loneliness as a Mediator of the Relationship between Cancer-related 
Negative Social Expectations and Quality of Life 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
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Avoidant coping 
Loneliness 
Quality of Life 
α =
 .39
***
 
b = -.45*** 
c’ = -.38*** 
c = -.54*** 
Figure 3i. Loneliness as a Mediator of the Relationship between Avoidant Coping and 
Quality of Life 
Standardized coefficients shown. c pathway = total effect of the independent variable on 
the dependent variable; c’ pathway = effect of the independent variable on the dependent 
variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
Beliefs about 
ability to cope with 
cancer 
Loneliness 
Quality of Life 
α =
 -.4
9**
* 
b = -.31*** 
c’ = .56*** 
c = .72*** 
Figure 3j. Loneliness as a Mediator of the Relationship between Beliefs about Ability to 
Cope with Cancer and Quality of Life 
Standardized coefficients shown. c pathway = total effect of the independent variable 
on the dependent variable; c’ pathway = effect of the independent variable on the 
dependent variable when controlling for the mediator (direct effect).  
* p < .05, ** p < .01, *** p < .001 
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Table 11. Loneliness, Depression, and Quality of Life at Time 2 (N=97) 
 M (SD) [Range] or N (%) 
Loneliness  
UCLA Loneliness Scale (UCLA V3) 35.5 (9.0) [23 – 58] 
Low (20-34) 45 (46%) 
Moderate (35-49) 44 (45%) 
Moderately High (50-64) 8 (8%) 
High (65+) 0 (0%) 
Depression  
Center for Epidemiologic Studies Depression 
Scale (CES-D) 
13.7 (9.3) [0 – 36] 
CES-D >16 34 (35%) 
Quality of Life  
Functional Assessment of Cancer Therapy – 
Lung (FACT-L) Total Score 
97.2 (20.9) [40 – 135] 
Physical Well-being (PWB) 19.0 (5.5) [1 – 28] 
Social/Family Well-being (SWB) 24.6 (3.9) [11 – 28] 
Emotional Well-being (EWB) 18.6 (4.5) [5 – 24] 
Functional Well-being (FWB) 16.4 (6.5) [3 – 28] 
Lung Cancer Subscale (LCS) 18.5 (5.4) [5 – 28] 
FACT-G 78.7 (16.9) [31 – 107] 
Treatment Outcome Index (TOI) 54.0 (15.8) [14 – 84] 
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Table 12. Two-step Hierarchical Linear Regression Treating Depression at Time 2 as the 
Dependent Variable 
 
 B SE β t (p-value) Δ R2 (p- 
value) 
Model 
Adj R2 
Step 1       
Depression T1 5.1 1.1 .43 9.8***  .17 
Step 2       
    Loneliness T1   .32   .1     .38 4.4*** .14    .31 
Note: B = unstandardized regression coefficient; SE = standard error of the estimate for 
step 1 or step 2; β = standardized regression coefficient 
 
 
 
 
 
Table 13. Two-step Hierarchical Linear Regression Treating Quality of Life at Time 2 as the 
Dependent Variable 
 
 B SE β t (p-value) Δ R2 (p- 
value) 
Model 
Adj R2 
Step 1       
Quality of Life T1 .73 .1 .68 9.0***  .46 
Step 2       
    Loneliness T1 .03 .2 .02 .2 -.01 .45 
Note: B = unstandardized regression coefficient; SE = standard error and standard error 
of the estimate for step 1 or step 2; β = standardized regression coefficient 
 
 
